Attached files
file | filename |
---|---|
8-K - FORM 8-K - Synaptogenix, Inc. | tm2114776d1_8k.htm |
Exhibit 99.1
SYNAPTOGENIX, INC.
BALANCE SHEETS
(Unaudited)
As Filed | Offering | Pro forma as of | ||||||||||
December 31, | Entries | December 31, | ||||||||||
2020 | January 2021 | 2020 | ||||||||||
ASSETS | ||||||||||||
CURRENT ASSETS | ||||||||||||
Cash and cash equivalents | $ | 5,795,055 | $ | 12,589,667 | $ | 18,384,722 | ||||||
Grant receivable | 127,445 | - | 127,445 | |||||||||
Prepaid expenses and other current assets | 806,289 | - | 806,289 | |||||||||
TOTAL CURRENT ASSETS | 6,728,789 | 12,589,667 | 19,318,456 | |||||||||
Fixed assets, net of accumulated depreciation | 22,212 | - | 22,212 | |||||||||
TOTAL ASSETS | $ | 6,751,001 | $ | 12,589,667 | $ | 19,340,668 | ||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||
CURRENT LIABILITIES | ||||||||||||
Accounts payable | $ | 1,260,335 | $ | - | $ | 1,260,335 | ||||||
Accrued expenses | 352,154 | - | 352,154 | |||||||||
TOTAL CURRENT LIABILITIES | 1,612,489 | - | 1,612,489 | |||||||||
Commitments and contingencies | ||||||||||||
SHAREHOLDERS' EQUITY | ||||||||||||
Preferred stock - 1,000,000 shares authorized as of December 31, 2020, $0.0001 par value; | ||||||||||||
0 shares issued and outstanding as of December 31, 2020 | ||||||||||||
Common stock - 150,000,000 shares authorized as of December 31, 2020, $0.0001 par value; | - | - | - | |||||||||
5,030,316 shares issued and outstanding as of December 31, 2020 | ||||||||||||
14,032,516 pro forma shares issued and outstanding as of December 31, 2020. | 503 | 900 | 1,403 | |||||||||
Additional paid-in capital | 6,668,482 | 12,588,767 | 19,257,249 | |||||||||
Accumulated deficit | (1,530,473 | ) | - | (1,530,473 | ) | |||||||
TOTAL SHAREHOLDERS' EQUITY | 5,138,512 | 12,589,667 | 17,728,179 | |||||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 6,751,001 | $ | 12,589,667 | $ | 19,340,668 |